Biomarkers in Chronic Kidney Disease: Clinical Role and Relevance Prognosis
PDF (Português (Brasil))

Keywords

Biomarkers
Prognostic
Chronic Kidney Disease

How to Cite

Gonçalves Zoppé, M., Nogueira da Costa , M., Franskoviak Cunha Silva, A. C., Lima de Freitas, F., Meneses dos Santos, L., Porcari Dutra Gaspar Rosa , A., Tavares Mariano, M. E., Fontana Gomes, C., & Gaburro Tozzi , M. (2024). Biomarkers in Chronic Kidney Disease: Clinical Role and Relevance Prognosis. Brazilian Journal of Implantology and Health Sciences, 6(7), 2364–2372. https://doi.org/10.36557/2674-8169.2024v6n7p2364-2372

Abstract

In summary, articles in Portuguese and English published between 2015 and 2024 were searched, with 11 articles accessed through the VHL, in the databases at the USA National Library of Medicine (PubMed), being selected. It was clear that the diagnosis of kidney disease is resolved when there is kidney damage for at least 3 months, confirmed by biopsy kidney disease or markers of kidney damage. After establish this diagnosis, it is necessary classify the disease into one of five stages. Furthermore, it is also important to say that. There are studies that confirm the relationship between CKD with cardiovascular diseases, osteoporosis and history of bone fractures. It follows then that it is extremely important that some biomarkers are evaluated for thus have a good prognosis.

https://doi.org/10.36557/2674-8169.2024v6n7p2364-2372
PDF (Português (Brasil))

References

BANSAL, N. et al. Cardiac Biomarkers and Risk of Incident Heart Failure in Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study. Journal of the American Heart Association, v. 8, n. 21, 5 nov. 2019.

BANSAL, N. et al. Change in cardiac biomarkers and risk of incident heart failure and atrial fibrillation in chronic kidney disease: the CRIC Study. American journal of kidney diseases : the official journal of the National Kidney Foundation, v. 77, n. 6, p. 907–919, 1 jun. 2021.

LI, Z.-X. et al. Osteoporosis biomarkers act as predictors for diagnosis of chronic renal insufficiency in elder patients. International Journal of Clinical and Experimental Medicine, v. 8, n. 4, p. 5949–5953, 15 abr. 2015.

MALHOTRA, R. et al. The Effect of Extended Release Niacin on Markers of Mineral Metabolism in CKD. Clinical Journal of the American Society of Nephrology, v. 13, n. 1, p. 36, 1 jan. 2018.

JOTWANI, V. et al. Tubular Biomarkers and Chronic Kidney Disease Progression in SPRINT Participants. American Journal of Nephrology, v. 51, n. 10, p. 797–805, 2020.

‌VALLIANOU, N. G. et al. Chronic Kidney Disease and Cardiovascular Disease: Is there Any Relationship? Current Cardiology Reviews, v. 15, n. 1, p. 55–63, 1 fev. 2019.

ZHAN, Z. et al. Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study. BMC Nephrology, v. 20, n. 1, 12 jul. 2019.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Milene Gonçalves Zoppé, Maria Nogueira da Costa , Ana Carolina Franskoviak Cunha Silva, Franciele Lima de Freitas, Leticia Meneses dos Santos, Anita Porcari Dutra Gaspar Rosa , Maria Eduarda Tavares Mariano, Catarina Fontana Gomes, Monique Gaburro Tozzi